Email Us
View Reports

Global Kaposi Sarcoma Market Analysis and Forecast 2016-2024 | Industry Growth Opportunities

  • ID : 1655134  |  
  • Published : Jan-2018  |  
  • Region : Global  |  
  • Pages : 310   |  
  • Publisher : Goldstein Research

Global Kaposi Sarcoma Market

Market Overview

Kaposi sarcoma (KS) is a cancer that develops from the cells that line lymph or blood vessels, abnormal cells of KS form purple, red, or brown blotches or tumors on the skin called as lesions. Types of Kaposi Sarcoma are:

• Epidemic (AIDS-related) Kaposi sarcoma

• Classic (Mediterranean) Kaposi sarcoma

• Endemic (African) Kaposi sarcoma

• Iatrogenic (transplant-related) Kaposi sarcoma

• Kaposi sarcoma in HIV negative men who have sex with men

Epidemic or AIDS-related KS is the most common type, develops in people who are infected with HIV, the virus that causes AIDS. In US, treatment of HIV infection with highly active antiretroviral therapy (HAART) has upshot the cases of epidemic KS and still some patients develop symptoms of KS in the initial months of HAART treatment.

In US, with the AIDS epidemic, the rate of KS increased more than 20 times — peaking at about 47 cases per million people (per year) in the early 1990s. Early in the AIDS epidemic, patients infected with HIV in the US were estimated to have a 50% probability of having KS. Transplant patients are another slot that gets KS, about 1 in 200 transplant patients in the United States gets KS.

“Imiquimod” (Aldara) is a topical drug that attunes the immune system and can be applied to the skin to treat certain kinds of warts and helping shrink KS skin lesions, as well. Similarly, Maraviroc (Selzentry) is also an antiretroviral drug currently being studied for its effect on Kaposi Sarcoma.

Market Segmentation

• By Diagnosis

o Biopsy

o Imaging

o X-ray

o Computed tomography (CT or CAT) scan

o Endoscopy

o Bronchoscopy

• By Treatment

o Antiretroviral Therapy (HAART)

o Chemotherapy

o Immunotherapy

• By End User

o Hospital

o Diagnostic centers

o Clinics

• By Geography

o North America (US, Canada) {Market Share (%), Market Size (USD Billion), Diagnosis (Number)}

o Europe (UK, France, Italy, Germany, Spain, Hungary, Sweden, Russia, Poland and Rest of Europe) {Market Share (%), Market Size (USD Billion), Diagnosis (Number)}

o Middle East and Africa (GCC Countries, North Africa, South Africa and Rest of Middle East & Africa) {Market Share (%), Market Size (USD Billion), Diagnosis (Number)}

o Latin America (Brazil, Mexico and Rest of Latin America) {Market Share (%), Market Size (USD Billion), Diagnosis (Number)}

o Asia Pacific (China, Japan, India, Singapore, South Korea, Australia, New Zealand and Rest of Asia-Pacific) {Market Share (%), Market Size (USD Billion), Diagnosis (Number)}

o Rest of the World {Market Share (%), Market Size (USD Billion), Diagnosis (Number)}

Growth Drivers and Challenges

Looming patent expiries of several blockbuster drugs, high rate of diagnosis of the condition, the easy availability of drugs, with the AIDS being epidemic, significant growth in the organ transplant procedures and introduction of innovative and generic drug as well as therapies are bolstering underlying demand for Kaposi Sarcoma market.

High cost across developing and less developed economies, shortage in supply of drugs due to wide demand-supply gap and less awareness among people limiting Kaposi sarcoma market growth prospects.

Market Size and Forecast (2016-2024)

Kaposi sarcoma market is making strides. According to Goldstein Research, global Kaposi sarcoma market has increased at a CAGR of 2.25% over the forecast period that will exhibit valuation of USD 0.15 billion by 2024 rising from USD 0.11 billion in 2016.

Based on treatments, antiretroviral therapy dominated the global Kaposi sarcoma market owing to the high incidence rate of AIDS-related Kaposi sarcoma and tends to grow at an encouraging pace in the forecast period as well. Biopsy is the first step to diagnose the Kaposi sarcoma while CT scan is usually done to determine if the cancer has spread to the lymph nodes, liver and lungs.

From region wise standpoint, North America is the leading contributor of revenue to the global Kaposi sarcoma market owing to high rate of diagnosis of the condition and the easy availability of drugs. Middle East and Africa region is the promising market of Kaposi sarcoma attributable to increased prevalence of AIDS induced Kaposi sarcoma in Eastern Africa.

Key Market Players

• Quest Diagnostics

o Synopsis

o Business Strategy

o Product Portfolio

o SWOT Analysis

• Johnson & Johnson

• Merck & Co. Inc.

• Bristol Myers Squibb

• Hoffman-La Roche Inc.

• Pfizer Inc.

• GlaxoSmithKline plc

• Eli Lilly and Co

• Navidea Biopharmaceuticals, Inc.

• MBio Diagnostics

• Cleveland Clinic

• Massachusetts General Hospital

• Mayo Foundation for Medical Education and Research (MFMER)

• The Johns Hopkins Hospital

• UCLA Health

• Royal Adelaide Hospital

• Cancer Institute Nsw

• Vancouver Coastal Health

Scope Background

Market Synopsis

Market Segmentation

Global Kaposi Sarcoma Market is segmented as follows:

• By diagnosis (Market Size, Demand Analysis and Growth Analysis)

• By treatment (Market Size, Demand Analysis and Growth Analysis)

• By end-user (Market Size, Demand Analysis and Growth Analysis)

Global Kaposi Sarcoma market report covered insights of below mentioned regions:

• North America (U.S., Canada) {Market Size, Growth Analysis and Opportunity Analysis}

• Latin America (Argentina, Mexico, Brazil and Rest of Latin America) {Market Size, Growth Analysis and Opportunity Analysis}

• Europe (Germany, Italy, Spain, France, The U.K., Netherlands, Sweden, Hungary, Russia, Poland, Rest of Europe) {Market Size, Growth Analysis and Opportunity Analysis}

• Asia-Pacific (China, India, Singapore, Japan, Australia, New Zealand, South Korea and Rest of Asia Pacific) {Market Size, Growth Analysis and Opportunity Analysis}

• Middle East and North Africa (MENA) {Market Size, Growth Analysis and Opportunity Analysis}

• Rest of World {Market Size, Growth Analysis and Opportunity Analysis}

Market Dynamics: Growth Drivers, Restraints and Opportunities

• Risk Factors

• Regional Variations

• Current Trends and Developments

Key Market Players

• Synopsis

• Business Strategy

• Product Portfolio

• SWOT Analysis

Porter’s Five Force Model

Market Landscape: Competition and Beyond

Market outlook for business players and entry level players to ascertain their business in dynamic ecosystem

Expert Analysis

Concluding Remarks

Table of Contents

1. Executive Summary

2. Research Methodology

3. Regional Opportunity Analysis on the basis of Competitors

4. Global Kaposi Sarcoma Market Size (USD Billion) and Forecast Analysis, 2016-2024

5. Market Dynamics: Growth Drivers, Restraints and Opportunities

5.1. Risk Factors

5.2. Regional Variations

5.3. Recent Trends and Developments

6. Global Kaposi Sarcoma Market Segmentation

6.1. Kaposi Sarcoma Market By Diagnosis (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)

6.1.1. Adoption Rate (%) of Kaposi Sarcoma Market by Diagnosis

6.1.2. Biopsy (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)

6.1.3. Imaging (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)

6.1.4. X-Ray (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)

6.1.5. Computed tomography (CT or CAT) scan (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)

6.1.6. Endoscopy (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)

6.1.7. Bronchoscopy (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)

6.1.8. Market Attractiveness of Kaposi Sarcoma Market by Diagnosis

6.1.9. BPS Analysis of Kaposi Sarcoma Market by Diagnosis

6.2. Kaposi Sarcoma Market By Treatment (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)

6.2.1. Adoption Rate (%) of Kaposi Sarcoma Market by Treatment

6.2.2. Antiretroviral Therapy (HAART) (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)

6.2.3. Chemotherapy (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)

6.2.4. Immunotherapy (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)

6.2.5. Market Attractiveness of Kaposi Sarcoma Market by Treatment

6.2.6. BPS Analysis of Kaposi Sarcoma Market by Treatment

6.3. Kaposi Sarcoma Market By End-User (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)

6.3.1. Adoption Rate (%) of Kaposi Sarcoma Market by End-User

6.3.2. Hospital (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)

6.3.3. Diagnostic centers (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)

6.3.4. Clinics (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)

6.3.5. Market Attractiveness of Kaposi Sarcoma Market by End-User

6.3.6. BPS Analysis of Kaposi Sarcoma Market by End-User

6.4. Kaposi Sarcoma Market By Region (Market Share (%) & Y-o-Y Growth Comparison, 2016-2024)

6.4.1. North America Kaposi Sarcoma Market (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)

6.4.1.1. North America Kaposi Sarcoma Market By Country (Market Share (%) & Y-o-Y Growth Comparison, 2016-2024)

6.4.1.1.1. U.S. Kaposi Sarcoma Market (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)

6.4.1.1.2. Canada Kaposi Sarcoma Market (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)

6.4.1.1.3. Market Attractiveness of Kaposi Sarcoma Market by Country

6.4.1.1.4. BPS Analysis of Kaposi Sarcoma Market by Country

6.4.1.2. North America Kaposi Sarcoma Market By Diagnosis (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)

6.4.1.2.1. Adoption Rate (%) of Kaposi Sarcoma Market by Diagnosis

6.4.1.2.2. Biopsy (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)

6.4.1.2.3. Imaging (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)

6.4.1.2.4. X-Ray (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)

6.4.1.2.5. Computed tomography (CT or CAT) scan (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)

6.4.1.2.6. Endoscopy (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)

6.4.1.2.7. Bronchoscopy (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)

6.4.1.2.8. Market Attractiveness of Kaposi Sarcoma Market by Diagnosis

6.4.1.2.9. BPS Analysis of Kaposi Sarcoma Market by Diagnosis

6.4.1.3. North America Kaposi Sarcoma Market By Treatment (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)

6.4.1.3.1. Adoption Rate (%) of Kaposi Sarcoma Market by Treatment

6.4.1.3.2. Antiretroviral Therapy (HAART) (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)

6.4.1.3.3. Chemotherapy (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)

6.4.1.3.4. Immunotherapy (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)

6.4.1.3.5. Market Attractiveness of Kaposi Sarcoma Market by Treatment

6.4.1.3.6. BPS Analysis of Kaposi Sarcoma Market by Treatment

6.4.1.4. North America Kaposi Sarcoma Market By End-User (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)

6.4.1.4.1. Adoption Rate (%) of Kaposi Sarcoma Market by End-User

6.4.1.4.2. Hospital (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)

6.4.1.4.3. Diagnostic centers (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)

6.4.1.4.4. Clinics (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)

6.4.1.4.5. Market Attractiveness of Kaposi Sarcoma Market by End-User

6.4.1.4.6. BPS Analysis of Kaposi Sarcoma Market by End-User

6.4.2. Europe Kaposi Sarcoma Market (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)

6.4.2.1. Europe Kaposi Sarcoma Market By Country (Market Share (%) & Y-o-Y Growth Comparison, 2016-2024)

6.4.2.1.1. UK Kaposi Sarcoma Market (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)

6.4.2.1.2. France Kaposi Sarcoma Market (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)

6.4.2.1.3. Italy Kaposi Sarcoma Market (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)

6.4.2.1.4. Germany Kaposi Sarcoma Market (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)

6.4.2.1.5. Spain Kaposi Sarcoma Market (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)

6.4.2.1.6. Hungary Kaposi Sarcoma Market (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)

6.4.2.1.7. Sweden Kaposi Sarcoma Market (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)

6.4.2.1.8. Russia Kaposi Sarcoma Market (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)

6.4.2.1.9. Poland Kaposi Sarcoma Market (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)

6.4.2.1.10. Rest of Europe Kaposi Sarcoma Market (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)

6.4.2.1.11. Market Attractiveness of Kaposi Sarcoma Market by Country

6.4.2.1.12. BPS Analysis of Kaposi Sarcoma Market by Country

6.4.2.2. Europe Kaposi Sarcoma Market By Diagnosis (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)

6.4.2.2.1. Adoption Rate (%) of Kaposi Sarcoma Market by Diagnosis

6.4.2.2.2. Biopsy (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)

6.4.2.2.3. Imaging (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)

6.4.2.2.4. X-Ray (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)

6.4.2.2.5. Computed tomography (CT or CAT) scan (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)

6.4.2.2.6. Endoscopy (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)

6.4.2.2.7. Bronchoscopy (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)

6.4.2.2.8. Market Attractiveness of Kaposi Sarcoma Market by Diagnosis

6.4.2.2.9. BPS Analysis of Kaposi Sarcoma Market by Diagnosis

6.4.2.3. Europe Kaposi Sarcoma Market By Treatment (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)

6.4.2.3.1. Adoption Rate (%) of Kaposi Sarcoma Market by Treatment

6.4.2.3.2. Antiretroviral Therapy (HAART) (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)

6.4.2.3.3. Chemotherapy (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)

6.4.2.3.4. Immunotherapy (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)

6.4.2.3.5. Market Attractiveness of Kaposi Sarcoma Market by Treatment

6.4.2.3.6. BPS Analysis of Kaposi Sarcoma Market by Treatment

6.4.2.4. Europe Kaposi Sarcoma Market By End-User (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)

6.4.2.4.1. Adoption Rate (%) of Kaposi Sarcoma Market by End-User

6.4.2.4.2. Hospital (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)

6.4.2.4.3. Diagnostic centers (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)

6.4.2.4.4. Clinics (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)

6.4.2.4.5. Market Attractiveness of Kaposi Sarcoma Market by End-User

6.4.2.4.6. BPS Analysis of Kaposi Sarcoma Market by End-User

6.4.3. Middle East & Africa Kaposi Sarcoma Market (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)

6.4.3.1. Middle East & Africa Kaposi Sarcoma Market By Country (Market Share (%) & Y-o-Y Growth Comparison, 2016-2024)

6.4.3.1.1. Gulf Cooperation Council Countries (GCC) Kaposi Sarcoma Market (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)

6.4.3.1.2. South Africa Kaposi Sarcoma Market (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)

6.4.3.1.3. North Africa Kaposi Sarcoma Market (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)

6.4.3.1.4. Rest of Middle East and Africa Kaposi Sarcoma Market (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)

6.4.3.1.5. Market Attractiveness of Kaposi Sarcoma Market by Country

6.4.3.1.6. BPS Analysis of Kaposi Sarcoma Market by Country

6.4.3.2. Middle East & Africa Kaposi Sarcoma Market By Diagnosis (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)

6.4.3.2.1. Adoption Rate (%) of Kaposi Sarcoma Market by Diagnosis

6.4.3.2.2. Biopsy (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)

6.4.3.2.3. Imaging (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)

6.4.3.2.4. X-Ray (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)

6.4.3.2.5. Computed tomography (CT or CAT) scan (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)

6.4.3.2.6. Endoscopy (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)

6.4.3.2.7. Bronchoscopy (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)

6.4.3.2.8. Market Attractiveness of Kaposi Sarcoma Market by Diagnosis

6.4.3.2.9. BPS Analysis of Kaposi Sarcoma Market by Diagnosis

6.4.3.3. Middle East & Africa Kaposi Sarcoma Market By Treatment (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)

6.4.3.3.1. Adoption Rate (%) of Kaposi Sarcoma Market by Treatment

6.4.3.3.2. Antiretroviral Therapy (HAART) (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)

6.4.3.3.3. Chemotherapy (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)

6.4.3.3.4. Immunotherapy (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)

6.4.3.3.5. Market Attractiveness of Kaposi Sarcoma Market by Treatment

6.4.3.3.6. BPS Analysis of Kaposi Sarcoma Market by Treatment

6.4.3.4. Middle East & Africa Kaposi Sarcoma Market By End-User (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)

6.4.3.4.1. Adoption Rate (%) of Kaposi Sarcoma Market by End-User

6.4.3.4.2. Hospital (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)

6.4.3.4.3. Diagnostic centers (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)

6.4.3.4.4. Clinics (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)

6.4.3.4.5. Market Attractiveness of Kaposi Sarcoma Market by End-User

6.4.3.4.6. BPS Analysis of Kaposi Sarcoma Market by End-User

6.4.4. Latin America Kaposi Sarcoma Market (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)

6.4.4.1. Latin America Kaposi Sarcoma By Country (Market Share (%) & Y-o-Y Growth Comparison, 2016-2024)

6.4.4.1.1. Brazil Kaposi Sarcoma Market (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)

6.4.4.1.2. Mexico Kaposi Sarcoma Market (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)

6.4.4.1.3. Rest of Latin America Kaposi Sarcoma Market (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)

6.4.4.1.4. Market Attractiveness of Kaposi Sarcoma Market by Country

6.4.4.1.5. BPS Analysis of Kaposi Sarcoma Market by Country

6.4.4.2. Latin America Kaposi Sarcoma Market By Diagnosis (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)

6.4.4.2.1. Adoption Rate (%) of Kaposi Sarcoma Market by Diagnosis

6.4.4.2.2. Biopsy (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)

6.4.4.2.3. Imaging (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)

6.4.4.2.4. X-Ray (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)

6.4.4.2.5. Computed tomography (CT or CAT) scan (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)

6.4.4.2.6. Endoscopy (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)

6.4.4.2.7. Bronchoscopy (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)

6.4.4.2.8. Market Attractiveness of Kaposi Sarcoma Market by Diagnosis

6.4.4.2.9. BPS Analysis of Kaposi Sarcoma Market by Diagnosis

6.4.4.3. Latin America Kaposi Sarcoma Market By Treatment (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)

6.4.4.3.1. Adoption Rate (%) of Kaposi Sarcoma Market by Treatment

6.4.4.3.2. Antiretroviral Therapy (HAART) (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)

6.4.4.3.3. Chemotherapy (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)

6.4.4.3.4. Immunotherapy (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)

6.4.4.3.5. Market Attractiveness of Kaposi Sarcoma Market by Treatment

6.4.4.3.6. BPS Analysis of Kaposi Sarcoma Market by Treatment

6.4.4.4. Latin America Kaposi Sarcoma Market By End-User (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)

6.4.4.4.1. Adoption Rate (%) of Kaposi Sarcoma Market by End-User

6.4.4.4.2. Hospital (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)

6.4.4.4.3. Diagnostic centers (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)

6.4.4.4.4. Clinics (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)

6.4.4.4.5. Market Attractiveness of Kaposi Sarcoma Market by End-User

6.4.4.4.6. BPS Analysis of Kaposi Sarcoma Market by End-User

6.4.5. Asia Pacific (APAC) Kaposi Sarcoma Market (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)

6.4.5.1. Asia Pacific Kaposi Sarcoma Market By Country (Market Share (%) & Y-o-Y Growth Comparison, 2016-2024)

6.4.5.1.1. China Kaposi Sarcoma Market (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)

6.4.5.1.2. Japan Kaposi Sarcoma Market (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)

6.4.5.1.3. India Kaposi Sarcoma Market (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)

6.4.5.1.4. Singapore Kaposi Sarcoma Market (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)

6.4.5.1.5. South Korea Kaposi Sarcoma Market (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)

6.4.5.1.6. Australia Kaposi Sarcoma Market (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)

6.4.5.1.7. New Zealand Kaposi Sarcoma Market (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)

6.4.5.1.8. Rest of APAC Kaposi Sarcoma Market (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)

6.4.5.1.9. Market Attractiveness of Kaposi Sarcoma Market by Country

6.4.5.1.10. BPS Analysis of Kaposi Sarcoma Market by Country

6.4.5.2. Asia Pacific Kaposi Sarcoma Market By Diagnosis (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)

6.4.5.2.1. Adoption Rate (%) of Kaposi Sarcoma Market by Diagnosis

6.4.5.2.2. Biopsy (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)

6.4.5.2.3. Imaging (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)

6.4.5.2.4. X-Ray (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)

6.4.5.2.5. Computed tomography (CT or CAT) scan (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)

6.4.5.2.6. Endoscopy (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)

6.4.5.2.7. Bronchoscopy (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)

6.4.5.2.8. Market Attractiveness of Kaposi Sarcoma Market by Diagnosis

6.4.5.2.9. BPS Analysis of Kaposi Sarcoma Market by Diagnosis

6.4.5.3. Asia Pacific Kaposi Sarcoma Market By Treatment (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)

6.4.5.3.1. Adoption Rate (%) of Kaposi Sarcoma Market by Treatment

6.4.5.3.2. Antiretroviral Therapy (HAART) (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)

6.4.5.3.3. Chemotherapy (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)

6.4.5.3.4. Immunotherapy (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)

6.4.5.3.5. Market Attractiveness of Kaposi Sarcoma Market by Treatment

6.4.5.3.6. BPS Analysis of Kaposi Sarcoma Market by Treatment

6.4.5.4. Asia Pacific Kaposi Sarcoma Market By End-User (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)

6.4.5.4.1. Adoption Rate (%) of Kaposi Sarcoma Market by End-User

6.4.5.4.2. Hospital (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)

6.4.5.4.3. Diagnostic centers (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)

6.4.5.4.4. Clinics (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)

6.4.5.4.5. Market Attractiveness of Kaposi Sarcoma Market by End-User

6.4.5.4.6. BPS Analysis of Kaposi Sarcoma Market by End-User

7. Competitive Outlook

7.1. Market Share of Major Players (2016)

7.2. Company Profiles

7.2.1. Quest Diagnostics

7.2.1.1. Company Synopsis

7.2.1.2. Business Strategy

7.2.1.3. Product Portfolio

7.2.1.4. SWOT Analysis

7.2.2. Johnson & Johnson

7.2.3. Merck & Co. Inc.

7.2.4. Bristol Myers Squibb

7.2.5. Hoffman-La Roche Inc.

7.2.6. Pfizer Inc.

7.2.7. GlaxoSmithKline plc

7.2.8. Eli Lilly and Co

7.2.9. Navidea Biopharmaceuticals, Inc.

7.2.10. MBio Diagnostics

7.2.11. Cleveland Clinic

7.2.12. Massachusetts General Hospital

7.2.13. Mayo Foundation for Medical Education and Research (MFMER)

7.2.14. The Johns Hopkins Hospital

7.2.15. UCLA Health

7.2.16. Royal Adelaide Hospital

7.2.17. Cancer Institute Nsw

7.2.18. Vancouver Coastal Health

8. Porter’s Five Force Model

9. Market Landscape: Competition and Beyond

10. Market outlook for business players and entry level players to ascertain their business in dynamic ecosystem

11. Expert Analysis

12. Concluding Remarks

Purchase this Market Research Report

REACH OUT TO US

Call us on : +1 888 709 8757

Drop us an email at : info@researchcosmos.com

HAVE A QUESTION?